期刊文献+

嗜麦芽窄食单胞菌对8种氟喹诺酮类抗生素的交叉耐药性及耐药现状的探讨 被引量:4

The investigation of resistant characteristics of Stenotrophomonas maltophilia to 8 Fluoroquinolones and other antibiotics
暂未订购
导出
摘要 目的观察嗜麦芽窄食单胞菌对8种氟喹诺酮类抗生素的交叉耐药性及其它各种抗生素耐药现状,以指导临床合理用药。方法采用纸片扩散法测定临床标本中分离的79株嗜麦芽窄食单胞菌对各种抗生素的体外抗菌活性,并比较了8种氟喹诺酮类药物的敏感性,同时比较分析环丙沙星与复方新诺明的体外抗菌活性。结果嗜麦芽窄食单胞菌对大多数β-内酰胺类抗生素耐药,对青霉素类、头孢他啶、头孢噻肟、头孢吡肟、氨曲南高度耐药,对亚胺培南100%耐药,含酶抑制剂的β-内酰胺类复合制剂如头孢哌酮/舒巴坦、哌拉西林/他唑巴坦敏感率较单用相应β-内酰胺类抗生素有所提高(P<0.05),阿莫西林/克拉维酸则无显著性变化;氨基糖苷类抗生素庆大霉素和阿米卡星也呈现高耐药性;氟喹诺酮类抗生素包括加替沙星、左氧氟沙星、氧氟沙星、依诺沙星、洛美沙星、环丙沙星、氟罗沙星敏感率最高;复方新诺明的体外抗菌活性低于氟喹诺酮类(诺氟沙星除外,P<0.05)。结论嗜麦芽窄食单胞菌感染治疗首选氟喹诺酮类抗生素和复方新诺明,严重感染可选用β-内酰胺/酶抑制剂复合制剂与氟喹诺酮类联合用药。 Objective In order to help clinieians choose antimicrobial agents, we investigate the multiple resistance of Stenotrophomonns maltophilia isolated in our hospital to Fluortrtuinolonns and non-qtfinolones.Methods K-B method was performed on 79 strains isolated in our hospital. Results Compared with Ciprofloxacin, Levofloxacin and Gatitloxacin showed the highest antibacterial activity against Stenotrophomonas maltophilia, their rates were 98.7% and 98.7% ( P 〈 0.05, P 〈 0.05). Ofloxaein as slightly lower them (94.7 %, 0.5 〈 P 〈 0.1 ). Ciprdloxacin, F.noxacin, Fleroxacin,Mefloxaeinhad had lower rates, which were 85. 5% ,88.2%(0.5〈 P 〈 0.75),86.8% (0.75 〈 P 〈 0.9) and 86.8% (0.75 〈 P 〈 0.9) respectively. SMZ/TMP and Nodloxacin have lower sensitive rates, which were 69.6 % ( P 〈 0.05 ) and 6 t. 8 % ( P 〈 0.05). 79 strains showed more higher resistance to antibiotics include most of β-lactams and aminoglycosides. Condusion The multiple resistance d Stenotrophoraonas maltophilla was investigated. The fluoroquinolones and SMZ/TMP have the highest antibacterial activity against Stenotrophomonas maltophilia.
出处 《中国实验诊断学》 2007年第1期90-93,共4页 Chinese Journal of Laboratory Diagnosis
关键词 嗜麦芽窄食单胞菌 氟喹诺酮类 抗菌活性 Stenotrophomonns maltophilla Fluoroqulnolones Antibacterial activity
  • 相关文献

参考文献12

  • 1Parreromi NJ, Bradbury JF. Stenotrophomonas, a new bacterialgenus for Xanthomonas maltophilia[J]. Int J Syst Bacteriof, 1993,43(3) :606.
  • 2Micozzi, A. M. Venditti and M. Monaco, A et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies[J].Clin Infect Dis,2000,31:705.
  • 3Sanschagrin F. J. Dufresne, and R. C. Levesque. Molecular heterogeneity of the L-1 metallo-lactamase family from Stenotrophomonas maltophilia[J]. Antimicrob Agents Chemother, 1998,42:1245.
  • 4Zhang L. X.-Z. Li, and K. Poole. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob[J]. Agents Chemother,2000,44:287.
  • 5Avison M B, Higgins C S and Ford P J. Dirrerential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia[J]. J Antimixrob Ch emother,2002,44(7): 1778.
  • 6Li XZ,Zhang L and IcKay GA. Poole K. Role of the acetyltransrerase AAC (6')-Iz modifying enzyme in aminogly coside resistance in Stenotrophomonas maltophilia[J].J Antimicrob Chemother,2003,51(4):803.
  • 7Lambert T.M.-C.Ploy and F. Denis. Characterization of the chromosomal asc(6')-Iz gene of Stenotrophomonas maltophilia[J]. Antimicrob Agents Chemother, 1999,43: 2366.
  • 8Stein, G. E. 1996. Pharmacokinetics and pharmacodynamics d newer fluoroquinolones[J]. Clin Infect Dis, 1996,23(Suppl.): S19.
  • 9Zhang L, Li XZ and Poole K.SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia[J], Antimicrob Agents Chemother,2001,45(12): 3497.
  • 10Sylvia Valdezate, Ana Vindel and Aurora Echeita. Topoisomerase Ⅱ and Ⅳ Quinolone Resistance-Determining Regions in Stenotrophomonas maltophilia Clinical Isolates with Different Levels of Quinolone Susceptibility[J]. Antimicrobial Agents and Chemotherapy,2002,46(3):665.

二级参考文献5

  • 1[1]NCCLS. Performance standards fori antimicrobial susceptibility testing:ninth informational supplement[M].1999,19:32,72.
  • 2[2]Sanders CC,Barry AL,Washington JA,et al..Detection of extended-spectrum beta-lactamases producing members of family Enterobacteriaceae with the vitek ESBL test[J].J Clin microbiol,1996,34:2997~3001.
  • 3[3]Bush K,Jacoby GA,Medeiros AA.Afunctional classification sheme for β-lactam and its correlation with molecular structure[J].Antimicrob Agents Chemother,1995 39:1211~1233.
  • 4[4]Lecso-Bomet M, Bergogne-Berezin E.Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta lactambeta-beta lactamase inhibitor combinations[J].J Antimicrob Chemother,1997 40:717~720.
  • 5[5]Poulos CD, Matsumura SO, Willey BM et al. In vitro activities of antimicrobial combinations against Stenotrophomonas maltophilia[J].Antimicrob Agants Chemother,1995,39(10):2220~2223.

共引文献19

同被引文献54

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部